Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.Margaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Journal of Clinical Oncology|2020Cited by 1
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCOREM Mir, Michele Marchioni, Riccardo Campi et al.|The Journal of Urology|2020Cited by 0